Bibliometric analysis reveals the current status and future trends of cancer associated photodynamic therapy in breast cancer
摘要
Photodynamic therapy (PDT) has emerged as a promising minimally invasive strategy for breast cancer, leveraging photosensitizing agents, light activation, and oxygen to generate cytotoxic effects. This bibliometric analysis explores the knowledge structure, evolutionary trends, and research frontiers within the PDT domain for breast cancer from 2000 to 2025.
MethodsData were retrieved from the Web of Science Core Collection and PubMed (2000–2025). A total of 3,785 publications were analyzed using Bibliometrix, VOSviewer, and CiteSpace for co-authorship, co-citation, keyword co-occurrence, and burst detection analyses.
ResultsAnnual publications grew markedly, peaking in 2025. China led in productivity and citations, while the Chinese Academy of Sciences showed the highest betweenness centrality. Biomaterials was the most influential journal, and author collaboration networks revealed limited connectivity among core researchers. Keyword evolution identified three phases: basic exploration (2000–2017), technical development (2013–2021), and the current precision immunomodulation era (2020–present), with “tumor microenvironment” and “immunogenic cell death” as dominant contemporary themes.
ConclusionThis study delineates the intellectual landscape and shifting paradigms in breast cancer PDT research, underscoring a transition toward immune-focused and tumor-microenvironment–modulating strategies. Future efforts should prioritize interdisciplinary collaboration and PDT–immunotherapy combinations to advance clinical translation.